SIOGEN Biotech voted ‘Most Innovative Biotech in Asia’ at BioPharma Industry Awards 2011

30-May-2011 - Malaysia

SIOGEN Biotech has been awarded the ‘Most Innovative Biotech in Asia Award’ for 2011. Presented at the BioPharma Industry Asia Awards in Singapore, held in conjunction with the 4th Annual BioPharma Asia Convention, the award recognises SIOGEN’s state of the art drug targeting and delivery technology Siosomes® and potential impact in the global pharmaceutical market.

Dr. Shermal Perera, Managing Director of SIOGEN, said, “Winning this award is further validation that Siosomes® can enable the improved, targeted delivery of a broad range of therapeutic agents. It is an exciting time for SIOGEN as our technology and creative partnering have led to a pipeline of smart therapeutics with indications in diseases ranging from tuberculosis to cancer. We are currently seeking joint venture partners and investment to set up our operations in the US, to expand our NanoVesicle technology into other markets.”

Nominations were invited from across the industry and more than 40,000 votes were cast to decide the award winners. In the ‘Most Innovative Biotech’ category, five companies were shortlisted on the basis of their innovation and novel approach in developing drugs. SIOGEN was voted the winner for its Siosomes® NanoVesicle platform technology and the creative collaborations it has established with research institutions, pharma and biotech companies worldwide.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?